Artemisine MedicinesOne rule that changed malaria care
Not long ago, most fever in endemic areas was treated as malaria on suspicion alone. WHO's good-practice rule today is unambiguous: every suspected malaria case should be confirmed by a parasitological test — microscopy or a rapid diagnostic test (RDT) — and both methods should run under a quality-assurance programme.
Why test first?
- Many fevers are not malaria: treating every fever wastes antimalarials and leaves the real illness — pneumonia, sepsis, dengue — untreated.
- Protects drug efficacy: unnecessary ACT use accelerates resistance.
- Protects budgets: programs that test first buy fewer, better-targeted treatment courses.
RDT vs microscopy at a glance
- RDTs: a finger-prick blood drop on a cassette, result in about 20 minutes, minimal training — ideal for community health workers and remote posts. Most detect P. falciparum HRP2 antigen; pan-malaria lines detect other species.
- Microscopy: the reference standard — identifies species and parasite density (important for hyperparasitaemia risk), but needs a microscope, stains and a trained microscopist.
What buyers should check
Procurement guidelines (WHO and Global Fund) call for RDTs with strong panel-detection scores, heat stability appropriate to the supply chain, and lot quality-control. For programs, pairing confirmed-diagnosis policy with ACT supply keeps treatment aligned to real cases — and makes tender volumes far more predictable.
Source: summarised in plain language from the WHO Guidelines for Malaria (10 September 2026), World Health Organization. This guide is for buyer education only — clinical decisions must follow the locally approved product insert and national treatment guidelines.
